Cargando…
HCC incidence after hepatitis C cure among patients with advanced fibrosis or cirrhosis: A meta‐analysis
BACKGROUND AND AIMS: HCV cure reduces but does not eliminate the risk of HCC. HCC surveillance is recommended in populations where the incidence exceeds 1.5% per year. In cirrhosis, HCC surveillance should continue after HCV cure, although it is uncertain if this should be indefinite. For patients w...
Autores principales: | Lockart, Ian, Yeo, Malcolm G. H., Hajarizadeh, Behzad, Dore, Gregory J., Danta, Mark, Abe, Kazumichi, Carrat, Fabrice, Lusivika‐Nzinga, Clovis, Degasperi, Elisabetta, Di Marco, Vito, Hou, Jinlin, Howell, Jessica, Janjua, Naveed Z, Wong, Stanley, Kumada, Takashi, Lleo, Ana, Persico, Marcello, Lok, Anna S, Wei, Lai, Yang, Ming, Nabatchikova, Ekaterina, Nguyen, Mindie H, Antonio Pineda, Juan, Reig, María, Shiha, Gamal, Yu, Ming‐Lung, Tsai, Pei‐Chien |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9303770/ https://www.ncbi.nlm.nih.gov/pubmed/35030279 http://dx.doi.org/10.1002/hep.32341 |
Ejemplares similares
-
Performance of the marginal structural cox model for estimating individual and joined effects of treatments given in combination
por: Lusivika-Nzinga, Clovis, et al.
Publicado: (2017) -
Outcome of very high-risk patients treated by Sotrovimab for mild-to-moderate COVID-19 Omicron, a prospective cohort study (the ANRS 0003S COCOPREV study)
por: Martin-Blondel, Guillaume, et al.
Publicado: (2022) -
Aspirin, chronic hepatitis B (CHB) and hepatocellular carcinoma (HCC)—will there ever be enough data?
por: Crane, Harry, et al.
Publicado: (2023) -
Perspectives on the Underlying Etiology of HCC and Its Effects on Treatment Outcomes
por: Ito, Takanori, et al.
Publicado: (2023) -
Trends in decompensated cirrhosis and hepatocellular carcinoma among people with a hepatitis B notification in New South Wales
por: Shah, Syed Hassan Bin Usman, et al.
Publicado: (2022)